接受细胞抑制剂治疗的晚期肝细胞癌患者的甲胎蛋白反应 - Suppr

Suppr

超能文献

Alpha-fetoprotein response in advanced hepatocellular carcinoma receiving cytostatic agent.

作者信息

Chen Li-Tzong, Shiah Her-Shyong, Chao Yee, Chang Jang-Yang, Cheng Li-Ting, Whang-Peng Jacqueline

出版信息

J Clin Oncol. 2009 Dec 20;27(36):e271; author reply e272. doi: 10.1200/JCO.2009.23.8311. Epub 2009 Nov 16.

DOI:10.1200/JCO.2009.23.8311

PMID:19917866

Abstract

摘要

相似文献

Alpha-fetoprotein response in advanced hepatocellular carcinoma receiving cytostatic agent.接受细胞抑制剂治疗的晚期肝细胞癌患者的甲胎蛋白反应

J Clin Oncol. 2009 Dec 20;27(36):e271; author reply e272. doi: 10.1200/JCO.2009.23.8311. Epub 2009 Nov 16.

Alpha-fetoprotein in hepatocellular carcinoma surveillance: wake not the dead.甲胎蛋白用于肝细胞癌监测：勿惊逝者。

Hepatology. 2011 Jul;54(1):376-7. doi: 10.1002/hep.24196.

Alpha-fetoprotein response after locoregional therapy for hepatocellular carcinoma.肝细胞癌局部区域治疗后的甲胎蛋白反应

J Clin Oncol. 2010 Feb 20;28(6):e99; author reply e100. doi: 10.1200/JCO.2009.26.7070. Epub 2010 Jan 19.

Alpha-fetoprotein in early hepatocellular carcinoma.

Gastroenterology. 2010 Jan;138(1):400-1. doi: 10.1053/j.gastro.2009.08.076. Epub 2009 Nov 20.

Evaluating patients with cirrhosis for hepatocellular carcinoma: value of clinical symptomatology, imaging and alpha-fetoprotein.评估肝硬化患者的肝细胞癌：临床症状、影像学检查及甲胎蛋白的价值

Oncology. 2007;72 Suppl 1:117-23. doi: 10.1159/000111717. Epub 2007 Dec 13.

alpha-fetoprotein response predicts survival benefits of thalidomide in advanced hepatocellular carcinoma.甲胎蛋白反应可预测沙利度胺对晚期肝细胞癌的生存益处。

Aliment Pharmacol Ther. 2005 Aug 1;22(3):217-26. doi: 10.1111/j.1365-2036.2005.02547.x.

[Chemotherapy of hepatocytoma--discrepancies between AFP activity and the progress of the disease].[肝细胞瘤的化疗——甲胎蛋白活性与疾病进展之间的差异]

Rinsho Hoshasen. 1979;24(2):335-6.

Plasma osteopontin level as a diagnostic marker of hepatocellular carcinoma in patients with radiological evidence of focal hepatic lesions.血浆骨桥蛋白水平作为具有局灶性肝病变影像学证据患者肝细胞癌的诊断标志物。

Tumori. 2013 Jan-Feb;99(1):100-7. doi: 10.1177/030089161309900117.

[Chronic hepatitis C presenting with a diagnosis of hepatocellular carcinoma].以肝细胞癌诊断呈现的慢性丙型肝炎

Ugeskr Laeger. 2014 Aug 11;176(33).

False-negative rate of abdominal sonography for detecting hepatocellular carcinoma in patients with hepatitis B and elevated serum alpha-fetoprotein levels.腹部超声检查对乙肝患者及血清甲胎蛋白水平升高患者检测肝细胞癌的假阴性率

AJR Am J Roentgenol. 2004 Aug;183(2):453-8. doi: 10.2214/ajr.183.2.1830453.

引用本文的文献

Association between early response of alpha-fetoprotein and treatment efficacy of systemic therapy for advanced hepatocellular carcinoma: A multicenter cohort study from China.甲胎蛋白早期反应与晚期肝细胞癌系统治疗疗效的关联：一项来自中国的多中心队列研究。

Front Oncol. 2023 Jan 4;12:1094104. doi: 10.3389/fonc.2022.1094104. eCollection 2022.

Long-Term Outcome After Liver Transplantation for Hepatocellular Carcinoma Following Yttrium-90 Radioembolization Bridging Treatment.钇-90放射性栓塞桥接治疗后肝细胞癌肝移植的长期预后

Ann Transplant. 2017 Apr 14;22:215-221. doi: 10.12659/aot.902595.

Telomerase inhibition decreases alpha-fetoprotein expression and secretion by hepatocellular carcinoma cell lines: in vitro and in vivo study.端粒酶抑制降低肝癌细胞系中甲胎蛋白的表达与分泌：体外和体内研究

PLoS One. 2015 Mar 30;10(3):e0119512. doi: 10.1371/journal.pone.0119512. eCollection 2015.

Highlights for α-fetoprotein in determining prognosis and treatment monitoring for hepatocellular carcinoma.甲胎蛋白在确定肝细胞癌的预后和治疗监测中的作用要点。

World J Gastroenterol. 2012 Dec 28;18(48):7242-50. doi: 10.3748/wjg.v18.i48.7242.

Impact of preoperative α-fetoprotein level on disease-free survival after liver transplantation for hepatocellular carcinoma.术前甲胎蛋白水平对肝癌肝移植后无病生存率的影响。

World J Surg. 2012 Aug;36(8):1824-31. doi: 10.1007/s00268-012-1587-z.

A randomised phase II study of pegylated arginine deiminase (ADI-PEG 20) in Asian advanced hepatocellular carcinoma patients.聚乙二醇化精氨酸脱亚氨酶（ADI-PEG 20）治疗亚洲晚期肝细胞癌的随机 II 期研究。

Br J Cancer. 2010 Sep 28;103(7):954-60. doi: 10.1038/sj.bjc.6605856. Epub 2010 Aug 31.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验